Penserra Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $38,298 - $74,613	-874 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $29,025 - $44,809	874 New	874 $37,000
Q3 2019 Nov 15, 2019	SELL	$26.26 - $34.86 $783,677 - $1.04 Million	-29,843 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $520,163 - $860,075	29,843 New	29,843 $790,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.